Darcy G. Mott - Sep 20, 2021 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Special Advisor
Signature
/s/ Darcy G. Mott
Stock symbol
HQY
Transactions as of
Sep 20, 2021
Transactions value $
-$232,344
Form type
4
Date filed
9/21/2021, 02:06 PM
Previous filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $140K +10K +11.49% $14.00* 97.1K Sep 20, 2021 Direct F1
transaction HQY Common Stock Sale -$351K -5.67K -5.84% $62.00 91.4K Sep 20, 2021 Direct F1, F2
transaction HQY Common Stock Sale -$21.1K -335 -0.37% $62.97 91.1K Sep 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Option (right to buy) Options Exercise $0 -10K -33.33% $0.00 20K Sep 20, 2021 Common Stock 10K $14.00 Direct F1, F3
holding HQY Stock Option (right to buy) 25K Sep 20, 2021 Common Stock 25K $25.39 Direct F3
holding HQY Stock Option (right to buy) 19.9K Sep 20, 2021 Common Stock 19.9K $41.28 Direct F3
holding HQY Stock Option (right to buy) 14.2K Sep 20, 2021 Common Stock 14.2K $61.72 Direct F4
holding HQY Stock Option (right to buy) 15.3K Sep 20, 2021 Common Stock 15.3K $73.61 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Darcy G. Mott is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3 The option is immediately exercisable.
F4 The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
F5 The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.